These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
341 related items for PubMed ID: 28775071
21. Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study. Salomon J, Stolz D, Domenighetti G, Frey JG, Turk AJ, Azzola A, Sigrist T, Fitting JW, Schmidt U, Geiser T, Wild C, Kostikas K, Clemens A, Brutsche M. Respir Res; 2017 Jan 11; 18(1):13. PubMed ID: 28077140 [Abstract] [Full Text] [Related]
24. Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective. Kerwin EM, Williams J. Ther Adv Respir Dis; 2013 Feb 11; 7(1):25-37. PubMed ID: 23296242 [Abstract] [Full Text] [Related]
25. Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan. Horita N, Kaneko T. Int J Chron Obstruct Pulmon Dis; 2015 Feb 11; 10():813-22. PubMed ID: 25960646 [Abstract] [Full Text] [Related]
26. The relationship between airflow obstruction, emphysema extent, and small airways function in COPD. Timmins SC, Diba C, Farrow CE, Schoeffel RE, Berend N, Salome CM, King GG. Chest; 2012 Aug 11; 142(2):312-319. PubMed ID: 22345381 [Abstract] [Full Text] [Related]
27. Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety. Ridolo E, Montagni M, Riario-Sforza GG, Baroni M, Incorvaia C. Ther Adv Respir Dis; 2015 Apr 11; 9(2):49-55. PubMed ID: 25691493 [Abstract] [Full Text] [Related]
28. Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison. Mahler DA, D'Urzo A, Bateman ED, Ozkan SA, White T, Peckitt C, Lassen C, Kramer B, INTRUST-1 and INTRUST-2 study investigators. Thorax; 2012 Sep 11; 67(9):781-8. PubMed ID: 22544891 [Abstract] [Full Text] [Related]
29. Computed tomography assessment of pharmacological lung volume reduction induced by bronchodilators in COPD. Tanabe N, Muro S, Oguma T, Sato S, Kiyokawa H, Takahashi T, Kudo M, Kinose D, Kubo T, Hoshino Y, Ogawa E, Hirai T, Mishima M. COPD; 2012 Aug 11; 9(4):401-8. PubMed ID: 22509949 [Abstract] [Full Text] [Related]
30. Nitrogen single-breath washout test for evaluating exercise tolerance and quality of life in patients with chronic obstructive pulmonary disease. Deus CAL, Vigário PS, Guimarães FS, Lopes AJ. Braz J Med Biol Res; 2018 Aug 11; 51(4):e7059. PubMed ID: 29490001 [Abstract] [Full Text] [Related]
31. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK. Edwards SC, Fairbrother SE, Scowcroft A, Chiu G, Ternouth A, Lipworth BJ. Int J Chron Obstruct Pulmon Dis; 2016 Aug 11; 11():2851-2858. PubMed ID: 27920512 [Abstract] [Full Text] [Related]
32. Comparison of the rapid effects of single inhalations of formoterol and tiotropium bromide on respiratory function and COPD symptoms in a randomized crossover study. Ohbayashi H. Respir Investig; 2017 Nov 11; 55(6):348-356. PubMed ID: 29153415 [Abstract] [Full Text] [Related]
33. Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study. Kerwin EM, Kalberg CJ, Galkin DV, Zhu CQ, Church A, Riley JH, Fahy WA. Int J Chron Obstruct Pulmon Dis; 2017 Nov 11; 12():745-755. PubMed ID: 28280319 [Abstract] [Full Text] [Related]
34. Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD. Manoharan A, Morrison AE, Lipworth BJ. Lung; 2016 Apr 11; 194(2):259-66. PubMed ID: 26758884 [Abstract] [Full Text] [Related]
35. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial. Bölükbas S, Eberlein M, Eckhoff J, Schirren J. Eur J Cardiothorac Surg; 2011 Jun 11; 39(6):995-1000. PubMed ID: 20970351 [Abstract] [Full Text] [Related]
36. Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD. Prakash A, Babu KS, Morjaria JB. Int J Chron Obstruct Pulmon Dis; 2015 Jun 11; 10():111-23. PubMed ID: 25609944 [Abstract] [Full Text] [Related]
37. Indacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patients. Mroz RM, Minarowski L, Chyczewska E. Adv Exp Med Biol; 2013 Jun 11; 756():23-8. PubMed ID: 22836615 [Abstract] [Full Text] [Related]
38. Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease. Matsushima S, Inui N, Yasui H, Kono M, Nakamura Y, Toyoshima M, Shirai T, Suda T. Pulm Pharmacol Ther; 2015 Feb 11; 30():11-5. PubMed ID: 25445929 [Abstract] [Full Text] [Related]
39. Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study. Incorvaia C, Riario-Sforza GG, Pravettoni C, Dugnani N, Paterniti F, Pessina L, Fumagalli M. Respir Med; 2007 Mar 11; 101(3):476-80. PubMed ID: 16919926 [Abstract] [Full Text] [Related]
40. Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study. Kim CJ, Yoon HK, Park MJ, Yoo KH, Jung KS, Park JW, Lim SY, Shim JJ, Lee YC, Kim YS, Oh YM, Kim S, Yoo CG. Int J Chron Obstruct Pulmon Dis; 2017 Mar 11; 12():1589-1596. PubMed ID: 28615931 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]